1. Home
  2. SSBI vs LSBPW Comparison

SSBI vs LSBPW Comparison

Compare SSBI & LSBPW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SSBI
  • LSBPW
  • Stock Information
  • Founded
  • SSBI 1982
  • LSBPW N/A
  • Country
  • SSBI United States
  • LSBPW China
  • Employees
  • SSBI N/A
  • LSBPW 758
  • Industry
  • SSBI Major Banks
  • LSBPW Biotechnology: Pharmaceutical Preparations
  • Sector
  • SSBI Finance
  • LSBPW Health Care
  • Exchange
  • SSBI Nasdaq
  • LSBPW Nasdaq
  • Market Cap
  • SSBI N/A
  • LSBPW N/A
  • IPO Year
  • SSBI 2006
  • LSBPW N/A
  • Fundamental
  • Price
  • SSBI $7.54
  • LSBPW $0.06
  • Analyst Decision
  • SSBI
  • LSBPW
  • Analyst Count
  • SSBI 0
  • LSBPW 0
  • Target Price
  • SSBI N/A
  • LSBPW N/A
  • AVG Volume (30 Days)
  • SSBI 19.0K
  • LSBPW N/A
  • Earning Date
  • SSBI 01-28-2025
  • LSBPW N/A
  • Dividend Yield
  • SSBI 2.12%
  • LSBPW N/A
  • EPS Growth
  • SSBI N/A
  • LSBPW N/A
  • EPS
  • SSBI N/A
  • LSBPW N/A
  • Revenue
  • SSBI $25,783,000.00
  • LSBPW N/A
  • Revenue This Year
  • SSBI N/A
  • LSBPW N/A
  • Revenue Next Year
  • SSBI N/A
  • LSBPW N/A
  • P/E Ratio
  • SSBI N/A
  • LSBPW N/A
  • Revenue Growth
  • SSBI N/A
  • LSBPW N/A
  • 52 Week Low
  • SSBI $5.68
  • LSBPW N/A
  • 52 Week High
  • SSBI $11.63
  • LSBPW N/A
  • Technical
  • Relative Strength Index (RSI)
  • SSBI 56.22
  • LSBPW N/A
  • Support Level
  • SSBI $6.95
  • LSBPW N/A
  • Resistance Level
  • SSBI $7.65
  • LSBPW N/A
  • Average True Range (ATR)
  • SSBI 0.20
  • LSBPW 0.00
  • MACD
  • SSBI 0.02
  • LSBPW 0.00
  • Stochastic Oscillator
  • SSBI 80.82
  • LSBPW 0.00

About LSBPW LakeShore Biopharma Co. Ltd

LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.

Share on Social Networks: